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Abstract
Introduction
The aim of this study was to examine whether low-grade inflammation (LGI) is associated
with a subsequently increased risk of infection.
Methods
We included 15,754 healthy participants from the Danish Blood Donor Study, who com-
pleted a questionnaire on health-related items. LGI was defined as a C-reactive protein
level between 3 and 10 mg/L. Infections were identified by ICD-10 codes in the Danish
National Patient Register and ATC-codes in the Danish Prescription Register. Multivariable
Cox proportional hazard analysis was used as the statistical model.
Results
During 53,302 person-years of observation, 571 participants were hospitalized for infection.
Similarly, during 26,125 person-years of observation, 7,276 participants filled a prescription
of antimicrobials. LGI was associated with increased risk of hospital-based treatment for
infection only among men (hazard ratio = 1.60, 95% confidence interval (CI): 1.10–2.34)
and specifically infections were abscesses and infections of the skin and subcutaneous tis-
sue. Similarly, LGI was associated with the overall use of antimicrobials among men, and
particularly with phenoxymethylpenicillin and broad-spectrum antimicrobials for treatment
of urinary tract infections. The difference between men and women was not statistically
significant.
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Conclusions
In a large cohort of healthy individuals, LGI was associated with an increased risk of infec-
tion among healthy male blood donors.
Introduction
C-reactive protein (CRP) is a well-known acute phase protein and a part of the innate immune
response. CRP levels increase rapidly during acute inflammation, and is elevated in several
pathological processes, including chronic inflammatory diseases, cancer, and tissue damage
[1]. CRP is secretedmainly by hepatocytes under transcriptional control by the cytokine IL-6.
CRP recognizes altered self and foreign molecules and activates the complement system, binds
to Fc receptors, and acts as an opsonin for various pathogens [2]. CRP could thus be a factor in
the clearance of infection.
Accordingly, CRP above 10 mg/L in plasma is routinely used as a marker of infection in the
clinical ward. An increased CRP level is associated with several diseases [3], and a CRP level
above 10 mg/L is associated with an increased risk of cardiovascular disease [4], rheumatoid
arthritis [5], hypertension [6], and colorectal cancer [7].
Slightly elevated CRP levels, also known as low-grade inflammation (LGI), is reported to
occur in approximately 10% of healthy individuals [4,8]; a result recently confirmed in the
Danish BloodDonor Study (DBDS) [9]. LGI is associated with cardiovascular disease [4] and
rheumatoid arthritis [5]. Furthermore, CRP is widely used in cardiovascular risk assessment
[4,10] and as a prognostic marker in e.g. non Hodgkin’s lymphoma and diffuse large B-cell
lymphoma [11,12]. CRP is, however, also positively associated with several lifestyle factors,
such as obesity, smoking, alcohol consumption, and highmeat consumption [13]. We recently
showed that combined oral contraception (OC) and obesity were strong predictors of LGI in
the DBDS study population [9]. We also reported that obesity is associated with a higher risk
of infection [14].
LGI may either reflect subclinical infection or it may be a result of immune activation and
exhaustion of immune cell subsets with consequently increased infection risk. An association
between LGI and risk of subsequent infection has been established in a few studies previously
[15–17]. The largest study showed an association between LGI and particularly pneumonia,
sepsis, and gram-negative infections [15]. The findings point to CRP as a potential modulator
of either risk or severity of infection.
To examine whether LGI is associated with an increased risk of infection, it is necessary to
minimize the effect of potential confounders. In this respect, blood donors—who represent a
particularly healthy subset of the population—are especially suitable as a study cohort.
Materials and Methods
Study population
The Danish BloodDonor Study has been described in detail previously [9,14,18–21].
Briefly, DBDS was initiated in March 2010 as a multicenter public-health study and bio
bank (www.dbds.dk). Currently, more than 100,000 blood donors aged 18–67 years participate
in the study. Participants filled out a four-page questionnaire on health-related items, regarding
current smoking status, alcohol consumption, physical activity, diet, anthropometric measure-
ments, and (among women) use of contraception, childbirth, and menopausal status. Plasma
samples were stored and donors granted permission to link their data to public registers.
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From 1 March to 31 December 2010, 25,941 participants were included in DBDS. CRP was
measured in plasma samples from 18,147 participants included betweenMarch and December
of whom 15,222 participants were included betweenMarch and August and 2,925 participants
between September and December.
CRP was measured by a commercially available, high-sensitivity assay on an automated sys-
tem (Ortho Vitros 5600, Ortho Clinical Diagnostics, Rochester, NY, USA).
Participants were excluded if they had missing responses to any of the following question-
naire items: current smoking status (1,998 participants), height (1,894), and weight (1,800).
Furthermore, participants with CRP above 10 mg/L were excluded (141) to prevent possible
cases of prevalent infection. In total, 1,159 women and 1,234 men were thus excluded leaving a
total of 15,754 participants with correspondingmeasurements of CRP for the analyses.
For more detailed information on the participants and the measurement of CRP, see
Sørensen et al. [9].
Identification of hospital visits due to infection
To identify the first infection-related hospital visit (including both hospital admission and out-
patient care), participants were followed from inclusion via the Danish National Patient Regis-
ter. The register was established in 1977 [22,23] and holds records of all hospital contacts in
Denmark with information on dates of admission and discharge.
Discharge information was based on the International Classification of Diseases, 8th Revi-
sion (ICD-8), until the end of 1993, and on the 10th revision thereafter [24].
Date and ICD-10 codes for a discharges with a diagnosis of infectionwere identified and
included apart from chronic infections (other than chronic tonsillitis), condyloma, fungal
infections, and parasitic infections.
Diagnosis codes are divided into different types, and we used A (primary diagnosis), B (sec-
ondary diagnosis), and G (underlyingmedical condition).
Infections were grouped into subgroups (previously defined in [14]): abscesses, infections of
the skin and subcutaneous tissue, ear- and respiratory tract infections, gastrointestinal infec-
tions, urinary tract and pelvic inflammatory diseases only among women.
For specific ICD-10 codes—see S1 File.
Identification of prescriptions of antimicrobials
Information on antimicrobial prescriptions was collected from The Danish National Prescrip-
tion Register (DNPR). DNPR was established in 1994 and maintains information on all pre-
scribed drugs dispensed from Danish pharmacies. This information includes the unique
personal identification number of the patient, the type of drug according to the Anatomical
Therapeutic Chemical classification system, and the date of prescription [25].
Dispensed prescriptions for all antimicrobial agents prescribed for oral treatment of bacte-
rial (J01x) or viral infections (J05x) were identified. Furthermore, national Danish guidelines
for primary care were followed for specific calculations on prescriptions resulting from infec-
tions of specific anatomical locations [26,27] and previously used in [14]. As a proxy for respi-
ratory tract infections, we evaluated the number of dispensed prescriptions for oral treatment
with phenoxymethylpenicillin: J01CE02 and specificmacrolides (erythromycin: J01FA01, roxi-
thromycin: J01FA06, and clarithromycin: J01FA09). Phenoxymethylpenicillin is the most fre-
quently used drug against upper respiratory tract infections, whereas macrolides are used in
case of penicillin allergy or against mycoplasma pneumonia. To assess skin infections, we used
dispensed prescriptions of dicloxacillin: J01CF01 and flucloxacillin: J01CF05. To assess urinary
tract infections, we used dispensed prescriptions of pivmecillinam (J01CA08) and
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sulfamethizole (J01EB02), which are the first-line empiric antimicrobials for treatment of
acute, uncomplicated urinary tract infections. In an additional analysis, we included other anti-
microbials that can also be used for treatment of urinary tract infections (pivampicillin:
J01CA02, ciprofloxacin: J01MA02, nitrofurantoin: J01XE01, and trimethoprim: J01EA01).
Ciprofloxacin can also be used for gastrointestinal infections.
Furthermore, an analysis was performedwith commonly prescribed broad-spectrumpeni-
cillins: amoxicillin (J01CA04) and amoxicillin with enzyme inhibitor (J01CR02). These antimi-
crobials do not reflect a specific anatomical site.
Comorbidity
Somemajor chronic diseases could be potential confounders associated with infection. To
assess the burden of disease, Charlson’s Comorbidity Score (CCS) [28] was included in the
analyses. This score is a weighted score of 17 major diseases identified by ICD-10 codes in
the National Patient Register. CCS includes congestive heart failure, chronic pulmonary dis-
ease, cerebrovascular disease, dementia, rheumatic disease, diabetes, renal disease, cancer,
liver disease, AIDS, and other diseases.We extended the score by adding hypertension (ICD-
10: I10, I111, I13, and I15), gastro-esophageal reflux (ICD-10: K21) [29], and atrial fibrilla-
tion (ICD-10: I48) [30], each weighted by one point. The Charlson Index for each participant
was calculated as a cumulative score for the 15 years before inclusion. As described previ-
ously, we categorized the participants as Charlson Index 0 (no comorbidity), Charlson Index
1 (participants with a score of 1), and Charlson Index 2 (participants with a score above one)
[31].
Definition of low-grade inflammation
We followed common practice by defining LGI as a CRP level above 3 mg/L and below or
equal to 10 mg/L [19,32,33].
Statistical analysis
Multivariable Cox proportional hazards analysis with age as the underlying timescale was used
to examine the association between LGI and treatment for infection at a hospital. Study partici-
pants were followed from the date of inclusion in DBDS until either the first infection-related
contact to the hospital, emigration, death, or end of follow-up (31 December 2013), whichever
came first. The same method was used to determine the association between LGI and receiving
prescriptions of antimicrobials, however, with follow-up until 31 December 2012.
The results were presented in two models. Model 1 represents a crude Cox proportional
hazard analysis without any adjustments. Model 2 includes adjustments for BMI 30 (yes/
no), comorbidity (using CCS defined as above), and current smoking status at inclusion (yes/
no). We decided to stratify for sex a priori because of the focus on sex-specific differences dis-
covered in earlier publications by others and us [14,29,34].
Interaction tests between LGI and the predictors were included in all models and removed
when confirmed insignificant. Furthermore, proportionality was checked by plotting the
observed and the fitted survival curves and log–log plots.
Data are presented as numbers, medians with ranges, or frequency statistics. Risk estimates
are presented as hazard ratios (HRs) with 95% confidence intervals (CIs).
Incidence rates are shown as events per year at risk.
Stata/MP 13.1 for windows (StataCorpLP, Texas, USA) was used for statistical analysis.
Low-Grade Inflammation and Risk of Infection
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Ethics
Oral and written informed consent was obtained from all participants. The Ethical Committee
of Central Denmark (M-20090237) approved the study. Additionally, the bio-bank and
research database were approved by the Danish Data Protection Agency (2007-58-0015).
Results
The characteristics of the participants at the time of inclusion have been reported previously
[9,14,18–21,35]. Characteristics relevant for this study are presented in Table 1.
There were no differences between the excluded participants and the participants in the
study with regard to sex distribution (P = 0.18). For age, however, there was a difference
(P = 0.009). Yet, comparing the mean value for age between the two groups; age was 39.7 for
the participants in the study and 40.5 for the excluded.
For participants with missing values for smoking, there was no difference with regard to
BMI (p = 0.30) or sex (p = 0.06), when compared to participants with available values. How-
ever, the participants with missing values were slightly older (40.5 vs. 39.6 years, p = 0.003).
For participants with missing values for BMI, there were no differences in distribution of
Table 1. Characteristics of the cohort.
Women Men
Numbers of participants 7,457 (47.3%) 8,297 (52.7%)
Age30 2,367 1,997
30>age40 1,736 2,152
40>age50 1,801 2,097
50>age60 1,152 1,426
Age>60 401 625
Age, years 37.8 (27.3; 47.9) 40.0 (30.3; 49.9)
Weight, kg 67.0 (61.0; 75.0) 84.0 (76.0; 92.0)
Height, cm 169 (165; 173) 182 (178; 187)
Waist, cm 82.0 (76.0; 90.0) 92 (86.0; 99.0)
BMI, kg/m2 23.5 (21.5; 26.2) 25.1 (23.3; 27.4)
Current smoker 1,281 (17.0%) 1,333 (16.1%)
Combined oral contraceptive pill (yes) 2,204 (29.6%) -
BMI, categorized, kg/m2
BMI<18.5 (underweight) 79 23
18.5BMI<25 (normal weight) 4,822 4,038
25BMI<30 (overweight) 1,842 3,386
BMI30 (obese) 714 850
CRP, mg/L 0.66 (0.17; 1.87) 0.41 (0.05; 1.09)
CRP>3 1,068 494
CRP>5 449 181
Treated for infection at a hospital 249 322
Charlson’s score 1a 197 207
Filled at least one prescriptions of antimicrobials 4,069 3,207
CRP3 0.5 (0.1; 1.2) 0.4 (0.1; 0.9)
3<CRP10 (LGI) 0.7 (0.2; 1.9) 0.4 (0.1; 1.1)
CRP>10 12.1 (11.0; 13.3) 11.5 (10.5; 12.6)
Numbers with percentages or medians with interquartile ranges.
a Charlson’s index were calculated 15 years prior to inclusion.
doi:10.1371/journal.pone.0164220.t001
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smoking (p = 0.12) or sex (p = 0.18). Again, for age the participants with missing values were
slightly older (40.5 vs 39.7 years). We consider the difference in age too small to affect results.
Low-grade inflammation and hospital-related treatment for infection
The results of the Cox regression analysis are presented in Table 2. During 53,302 years at risk,
571 participants received treatment for infection at a hospital. Overall, LGI was associated with
risk of subsequent infection (crudeHR = 1.31, CI: 1.03–1.68). However, when additional
adjustment for current smoking status and obesity was applied the association waned (adjusted
HR = 1.21, CI: 0.94–1.56).
After stratifying for sex, baseline LGI was associated with an increased risk of subsequent
infection among men (HR = 1.74, CI: 1.21–2.51) but only a slight tendency was observed
among women (HR = 1.18, CI: 0.81–1.59). There was however, not a significant difference
betweenmen and women. The difference betweenmen and women was not statistically signifi-
cant (interaction between sex and LGI: P = 0.116).
Table 2. The association between low-grade inflammation and infection.
WOMEN MEN
c Model 1 d Model 2 Model 1 Model 2
Site of infection a N b IR HR (95% CI) HR (95% CI) N IR HR (95% CI) HR (95% CI)
Infections overall 249 322
CRP3 (reference) 208 9.6 1 1 290 11.0 1 1
3<CRP10 (LGI) 41 11.3 1.14 (0.81–
1.59)
1.06 (0.75–
1.50)
32 19.3 1.74 (1.21–
2.51)
1.60 (1.10–
2.34)
Abscesses 49 67
CRP3 (reference) 42 1.9 1 1 58 2.2 1 1
3<CRP10 (LGI) 7 1.9 0.96 (0.43–
2.14)
0.80 (0.35–
1.82)
9 5.3 2.66 (1.31–
5.39)
2.19 (1.06–
4.54)
Infections of the skin and subcutaneous tissue 35 90
CRP3 (reference) 31 1.4 1 1 78 2.9 1 1
3<CRP10 (LGI) 4 1.1 0.71 (0.25–
2.05)
0.87 (0.31–
2.49)
12 7.1 2.52 (1.36–
4.65)
2.07 (1.09–
3.90)
Ear- and respiratory tract infections 82 81
CRP3 (reference) 70 3.2 1 1 72 2.7 1 1
3<CRP10 (LGI) 12 3.3 0.97 (0.52–
1.79)
0.98 (0.52–
1.83)
9 5.3 1.90 (0.94–
3.81)
1.80 (0.88–
3.68)
Gastrointestinal infections 50 57
CRP3 (reference) 40 1.3 1 1 51 1.4 1 1
3<CRP10 (LGI) 10 1.5 1.53 (0.76–
3.07)
1.45 (0.70–
2.98)
6 1.6 1.92 (0.82–
4.50)
1.81 (0.76–
4.33)
Urinary tract infections and pelvic inflammatory diseases
(women only)
42
CRP3 (reference) 31 1.4 1 1
3<CRP10 (LGI) 11 3.0 1.89 (0.94–
3.77)
1.66 (0.81–
3.40)
Multivariable cox proportional hazards analysis was performed with LGI as predictor with age as the underlying timescale.
LGI is defined as a c-reactive protein (CRP) level between 3 and 10 mg/L.
a N: number of cases.
b IR: incidence rate per 1000 person-years.
c Model 1: multivariable cox proportional hazards analysis was performed with low-grade inflammation (LGI) as predictor.
d Model 2: multivariable-adjusted model based on model 1 with additional adjustments for obesity, current smoking status, and comorbidity.
doi:10.1371/journal.pone.0164220.t002
Low-Grade Inflammation and Risk of Infection
PLOS ONE | DOI:10.1371/journal.pone.0164220 October 4, 2016 6 / 13
Among men, LGI was most strongly associatedwith abscesses (HR = 2.66, CI: 1.31–5.39) and
infections of the skin and subcutaneous tissue (HR = 2.52, CI: 1.36–4.65).When additional adjust-
ment for current smoking status and obesity was applied, the associations were slightly attenuated
for infections overall (HR = 1.60, CI: 1.10–2.34) and similarly for abscesses (HR = 2.19, CI: 1.06–
4.54) and infections of the skin and subcutaneous tissue (HR = 2.07, CI: 1.09–3.90).
Additional adjustment for OC use among women did not alter results (data not shown).
Low-grade inflammation and prescriptions of antimicrobials
The results are presented in Table 3. During 26,125 years at risk, 7,276 participants dispensed
at least one prescription of antimicrobials. Overall, LGI was associated with risk of prescrip-
tions (crudeHR = 1.27, CI: 1.18–1.37 and adjusted HR = 1.23, CI: 1.15–1.22).
Table 3. The association between low-grade inflammation and prescriptions of antimicrobials.
WOMEN MEN
Site of infection Model 1c Model 2d Model 1 Model 2
Type of prescription Na IRb HR (95% CI) HR (95% CI) N IR HR (95% CI) HR (95% CI)
Antimicrobials overall 4,069 3,207
CRP3 (reference) 3,455 332.0 1 1 2,986 200.1 1 1
3<CRP10 (LGI) 614 370.1 1.08 (0.99–
1.18)
1.05 (0.96–
1.15)
221 248.2 1.22 (1.07–
1.40)
1.17 (1.02–
1.35)
Phenoxymethylpenicillin 2,097 1,951
CRP3 (reference) 1,770 134.0 1 1 1,806 108.0 1 1
3<CRP10 (LGI) 327 151.0 1.13 (1.00–
1.27)
1.06 (0.93–
1.19)
145 141.9 1.29 (1.09–
1.52)
1.22 (1.03–
1.45)
Erythromycin, roxithromycin, and clarithromycin 677 559
CRP3 (reference) 550 36.8 1 1 516 27.9 1 1
3<CRP10 (LGI) 127 51.8 1.46 (1.20–
1.77)
1.31 (1.07–
1.60)
43 37.2 1.28 (0.93–
1.74)
1.25 (0.91–
1.72)
Dicloxacillin/flucloxacillin 367 432
CRP3 (reference) 321 20.9 1 1 394 21.0 1 1
3<CRP10 (LGI) 46 17.9 0.88 (0.64–
1.20)
0.81 (0.59–
1.12)
38 32.4 1.54 (1.10–
2.16)
1.29 (0.92–
1.82)
Pivmecillinam and sulfamethizole 1,156 119
CRP3 (reference) 980 68.3 1 1 111 5.8 1 1
3<CRP10 (LGI) 176 73.5 1.00 (0.85–
1.17)
1.02 (0.87–
1.21)
8 6.6 0.97 (0.47–
1.99)
1.02 (0.49–
2.13)
Pivampicillin, ciprofloxacin, nitrofurantoin, and
trimethoprim
467 305
CRP3 (reference) 377 24.8 1 1 277 14.7 1 1
3<CRP10 (LGI) 90 35.7 1.35 (1.07–
1.71)
1.34 (1.05–
1.70)
28 23.7 1.61 (1.09–
2.38)
1.72 (1.15–
2.55)
Amoxicillin and amoxicillin + enzymeinhibitor 325 286
CRP3 (reference) 272 17.7 1 1 261 13.8 1 1
3<CRP10 (LGI) 53 20.6 1.26 (0.94–
1.70)
1.19 (0.88–
1.62)
25 21.0 1.37 (0.91–
2.07)
1.17 (0.77–
1.78)
Multivariable cox proportional hazards analysis was performed with LGI as predictor with age as the underlying timescale.
LGI is defined as a c-reactive protein (CRP) level between 3 and 10 mg/L.
a N: number of cases.
b IR: incidence rate per 1000 person-years.
c Model 1: multivariable cox proportional hazards analysis was performed with low-grade inflammation (LGI) as predictor.
d Model 2: multivariable-adjusted model based on model 1 with additional adjustments for obesity, current smoking status, and comorbidity.
doi:10.1371/journal.pone.0164220.t003
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After stratifying for sex, LGI was associatedwith increased risk of prescriptions for oral anti-
microbial agents overall among men (HR = 1.22, CI: 1.07–1.40) but again, only a slightly ten-
dency was observed among women (HR = 1.08, CI: 0.99–1.18). Similar to the analysis above,
the difference betweenmen and women was not significant although a tendency was found
(interaction between sex and LGI: P = 0.213).
The strongest effects among men were seen with phenoxymethylpenicillin (HR = 1.29, CI:
1.09–1.52), dicloxacillin/flucloxacillin(HR = 1.54, CI: 1.10–2.16), and with pivampicillin/cip-
rofloxacin/nitrofurantoin/trimethoprim (HR = 1.61, CI: 1.09–2.16). After additional adjust-
ments for current smoking, obesity, and comorbidity, the associations were only slightly
reduced: antimicrobials overall (HR = 1.17, CI: 1.02–1.35), for phenoxymethylpenicillin
(HR = 1.22, CI: 1.03–1.45), and for pivampicillin/ciprofloxacin/nitrofurantoin/trimethoprim
the association increased (HR = 1.72, CI: 1.15–2.55), while the association for dicloxacillin/flu-
cloxacillin were now only a tendency. Among women an association was observed for phenox-
ymethylpenicillin,macrolides, and for pivampicillin/ciprofloxacin/nitrofurantoin/
trimethoprim.However, with additional adjustments for current smoking, obesity, and comor-
bidity, only the association between LGI and macrolides and LGI and pivampicillin/ciprofloxa-
cin/nitrofurantoin/trimethoprim persisted (see Table 3).
Additional adjustment for OC use among women did not alter results (data not shown).
The association was not caused by an ongoing infection at inclusion
To ensure that the positive association between LGI and infection was not caused by an ongo-
ing infection at inclusion, specific analyses were done with exclusion of hospital admissions/
dispensed prescriptions within 30 days after inclusion. The omission did not change results.
Thus, for hospital-related treatment for infection overall the HR associated with LGI for model
2 was 1.61 (CI: 1.11–2.35) among men and 1.07 (CI: 0.76–1.52) among women. Similarly, for
dispensed prescriptions of antimicrobials overall the HR for model 2 was 1.16 (CI: 1.01–1.34)
among men and 1.04 (CI: 0.95–1.14) among women. Similar findings were found for all sub-
groups and were consistent to the findings in Tables 2 and 3.
Discussion
LGI was associated with increased risk of subsequent infection among men in this large cohort
of healthy individuals. The association was evident both when defining an infectious event as a
hospital contact due to infection and as a dispensed prescription of an antimicrobial. With
respect to specific associations, the strongest were found for hospital contacts due to abscesses
and to infections of the skin and subcutaneous tissue. Similarly, for dispensed prescriptions of
phenoxymethylpenicillin; the most frequently used drug against upper respiratory tract infec-
tions and pivampicillin/ciprofloxacin/nitrofurantoin/trimethoprim; commonly used to treat
urinary tract infections. An association among women was only found for macrolides and
pivampicillin/ciprofloxacin/nitrofurantoin/trimethoprim.
To our knowledge, an association between LGI and later susceptibility to infection has not
been described in healthy individuals previously.
The association was not driven by admissions/prescriptions in the month succeeding inclu-
sion. Infections which were subclinical at donation and evolved to clinical infections within
short time after donation, were thus not likely the explanation.
Obesity is a major determinant of LGI [36,37] and increased levels of CRP can predict the
development of type 2 diabetes, metabolic syndrome [38,39], and insulin resistance [40].
Weight loss leads to CRP decrease [41], and patients with type 2 diabetes are at increased risk
of infection [42]. We recently found that obesity is associated with increased risk of infection
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[14]. The infections associated with obesity are similar to the infections associated with LGI in
the current study; namely, abscesses and infections of the skin and subcutaneous tissue. How-
ever, LGI was independently associated to infectionwith only a slight effect on HR estimates of
obesity adjustment.
Smoking and alcohol consumption are also determinants of LGI [9,13]. Smoking has previ-
ously been associated with risk of infection [43]. We adjusted for current smoking status, and
the adjustments had only minor effects on our results.
Additional adjustment for alcohol consumption was included in a separate analysis due to
the high percentage of missing answers. The adjustment did not alter conclusions (data not
shown).
Similarly, the analyses were adjusted for various forms of comorbidities (using CCS); yet
only a small percentage had comorbidities and CCS had no significant impact on our results
(see internal and external validity).
Among women, the use of OCwas a main cause of LGI [9] and there was no consistent
association between LGI and infectious events in this group. All analyses on women were
repeated with additional adjustments for OC use (data not shown). The use of OCwas not
associated with infection and in supplementary stratified analyses among women not taking
OC, we did not see stronger associations between LGI and infectious events. Thus, there was
no indication that OC use with subsequent LGI should mask an underlying association
between LGI and infection.
The association does not seem to be explained by relevant confounders even though residual
confounding cannot be ruled out. It can therefore be concluded that LGI was independently
associated with risk of infection among men. Only a few other studies have assessed this associ-
ation and none of these included individuals who were selected to be healthy at inclusion.
Because blood donors are thoroughly screened for symptoms at every visit to the blood bank
and deferred if not asymptomatic, this study supports that LGI and increased risk of infection
are not simply caused by an underlying disease. In stead we share the hypothesis, suggested by
another study [15], namely that LGI may represent a low-level immune activation that—if it
persists—could ultimately lead to exhaustion of immune cells and a reduced ability to resist
infections. Alternatively, donors with subclinical infections develop LGI and also have a ten-
dency to more frequent clinical infections.
Internal and external validity and Limitations
The validity of the study was strengthened by a well characterized and uniformly asymptomatic
study population at baseline. The data collectionwas structured and participation rate was
high. Blood donors must comply with strict criteria to be allowed to donate and are perma-
nently excluded from blood donation if diagnosedwith chronic diseases such as diabetes, can-
cer, hypertension, or even statin-treated hypercholesterolemia. In this study, only 3.2% of the
participants had a CCS 1 and adjustment for CCS or excluding participants with a score 1
did not affect the results. The participants were followed for a maximum of 2.75 years. Conse-
quently, the time at risk of comorbidity was short. The short follow-up increases the likelihood
that the exposure variable was constant during the follow-up, and CRP is relatively constant
over time [44]. CRP was only assessed once in this study.
End points was defined by two different approaches to define end points; namely, ICD-10
codes, and dispensed prescriptions of antimicrobials
There are limited data on the validity of infection-related ICD-10 codes; however, a large
review showed, that the Danish national patient register is a valuable tool for epidemiological
research [45].
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ATC-codes reflect the medicine that the participants received. As such, the codes serve as a
proxy for the occurrence of an infection; yet it is well known that antimicrobials are often pre-
scribed outside of their proper indication. The manner in which general practitioners treat
infections can vary. For mild, uncomplicated infections, some general practitioners are proba-
bly more inclined to treat with antibiotics than others, some use broad-spectrumantibiotics
where narrow-spectrumantibiotics could have been used, and others are inclined towards
waiting for the immune system to clear the infection.
It should be noted that although we observed a direct correlation between LGI and infection
susceptibility, this could also be explained by a causal model in which the individuals with LGI
have an underlying disorder that leads to more frequent hospital-related treatment for infec-
tion and use of antimicrobials. Our inclusion of comorbidity as an adjustment does not indi-
cate that an underlying disorder is the reason for the association.
Blood donors are only allowed to donate if they report that they feel perfectly healthy and
they are to report use of medication. At every donation, the blood donors are asked again and
whether they have consulted a doctor since last donation. Persons with known diabetes are not
allowed to donate blood—but because blood sugar levels are not measured in the blood banks,
undiagnoseddiabetes and impaired fasting glucose among the participants cannot be ruled
out. Similarly, for other diseases associated with LGI, e.g. cancer, cardiovascular disease and
autoimmune diseases, no screening apart from the questionnaire is performed. Because these
diseasesmay also alter the susceptibility to infection, we can only conclude that our findings
apply to self-reported healthy individuals.
We chose a priori to stratify for sex, however, in combined analysis of men and women only
a tendency to a difference in the effect of LGI was found between sexes. Moreover, the high
number of tests performed could lead to false positive findings and confirmation in other
cohorts would be valuable.
Conclusion
This first ever study on LGI and subsequent infection among self-reported healthy individuals
showed that LGI was associated with subsequent susceptibility to infection among men, mainly
involving abscesses and other infections of the skin and subcutaneous tissue, the use of phenox-
ymethylpenicillin, and antimicrobials for treatment of urinary tract infections.
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